Literature DB >> 9846828

Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes.

J P Lai1, S D Douglas, E Rappaport, J M Wu, W Z Ho.   

Abstract

We have characterized preprotachykinin (PPT-A) gene transcript splicing products and identified a fourth isoform of PPT-A mRNA transcript in human peripheral blood-isolated monocytes and PBL. Using RT-PCR, Southern blot analysis and nucleotide sequencing analysis, we have identified the four isoforms of PPT-A transcripts (alpha, beta, gamma and delta) in human peripheral blood-isolated monocytes and PBL. The delta-PPT transcript present in the immune cells lacks exons 4 and 6. The sequences of exons 3, 5 and 7 of delta-PPT transcript completely match those of beta-PPT transcript. The alpha-PPT and beta-PPT sequences in these cells are identical to those obtained by Tan and Too (GenBank accession number U37539) and Harmar et al. (Genbank accession number X54469), but differ by a single nucleotide from another entry by Chiwakata et al. (Genbank accession number M68906). In comparison to this latter sequence, there was a C-->T change at amino acid position 87 (CCT-->CTT) which may result in a Pro to Leu change. Identification of the new SP mRNA transcript in both human CNS and immune cells supports the concept of an important biological link between CNS and immune system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846828     DOI: 10.1016/s0165-5728(98)00170-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

1.  Monocytes/macrophages in diagnosis and immunopathogenesis.

Authors:  S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Characterization of the endokinins: human tachykinins with cardiovascular activity.

Authors:  Nigel M Page; Nicola J Bell; Sheila M Gardiner; Isaac T Manyonda; Kerensa J Brayley; Philip G Strange; Philip J Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

3.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

4.  Translocation of Bax and Bid to mitochondria, endoplasmic reticulum and nuclear envelope: possible control points in apoptosis.

Authors:  Barbara Gajkowska; Urszula Wojewódzka; Joanna Gajda
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

Review 5.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

6.  Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA.

Authors:  Jian-Ping Lai; Steven D Douglas; Yan-Jian Wang; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

Review 7.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.

Authors:  Jian-Ping Lai; Avital Cnaan; Huaqing Zhao; Steven D Douglas
Journal:  J Neurosci Methods       Date:  2007-10-17       Impact factor: 2.390

9.  Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.

Authors:  Yuan Li; Steven D Douglas; David E Pleasure; Jianping Lai; Changjiang Guo; Peter Bannerman; Marge Williams; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2003-02-15       Impact factor: 4.164

10.  Quantification of CCR5 mRNA in human lymphocytes and macrophages by real-time reverse transcriptase PCR assay.

Authors:  Jian-Ping Lai; Ji-Hong Yang; Steven D Douglas; Xu Wang; Eric Riedel; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.